Cooled tip radiofrequency ablation of benign thyroid nodules: preliminary experience with two different devices
Articolo
Data di Pubblicazione:
2018
Abstract:
Background: Thyroid nodules are very common in general population. Even if benign, they may require a
treatment in case of symptoms or cosmetic concerns. In the last years, minimally invasive treatments alternative
to surgery have been developed, in particular ultrasound (US) guided radiofrequency ablation (RFA).
Methods: Twenty-four patients (9 males; 15 females; mean age 57.9 years) were treated and divided
in two groups (A and B) according to the RFA needle used (18 gauge needle, AMICA; 17 gauge needle,
COVIDIEN). Nodules and patients characteristics, together with procedural data were registered pretreatment
and at 1-month follow-up. US visibility of the needle, volume of the nodules, symptoms and
cosmetic concerns, complications were registered.
Results: Visibility of the needle was not significantly different in the two groups (P=0.0787). At 1 month
the mean volume of the nodules dropped from 37.1 to 25 mL in group A and from 23.2 to 15.4 mL in group
B; shrinkage rate (36.9% and 39.5%, respectively) was not significantly different (P=0.3137). Symptoms
decreased from 3.1 to 1.4 in group A and from 4 to 1.6 in group B: no significant differences in reductions
were observed (P=0.3305). Cosmetic score decreased from 3.7 to 3.4 in group A and from 3.9 to 3.6 in group
B: no significant differences in reductions were observed (P=0.96). Total complication rate (18.2% in group
A vs. 23.1% in group B) did not showed significant differences (P=0.5049).
Conclusions: The two systems used in our study resulted equivalent in terms of US needle visibility,
efficacy, symptom/cosmetic relief, safety. More patients and a longer follow-up are necessary to confirm our
results.
treatment in case of symptoms or cosmetic concerns. In the last years, minimally invasive treatments alternative
to surgery have been developed, in particular ultrasound (US) guided radiofrequency ablation (RFA).
Methods: Twenty-four patients (9 males; 15 females; mean age 57.9 years) were treated and divided
in two groups (A and B) according to the RFA needle used (18 gauge needle, AMICA; 17 gauge needle,
COVIDIEN). Nodules and patients characteristics, together with procedural data were registered pretreatment
and at 1-month follow-up. US visibility of the needle, volume of the nodules, symptoms and
cosmetic concerns, complications were registered.
Results: Visibility of the needle was not significantly different in the two groups (P=0.0787). At 1 month
the mean volume of the nodules dropped from 37.1 to 25 mL in group A and from 23.2 to 15.4 mL in group
B; shrinkage rate (36.9% and 39.5%, respectively) was not significantly different (P=0.3137). Symptoms
decreased from 3.1 to 1.4 in group A and from 4 to 1.6 in group B: no significant differences in reductions
were observed (P=0.3305). Cosmetic score decreased from 3.7 to 3.4 in group A and from 3.9 to 3.6 in group
B: no significant differences in reductions were observed (P=0.96). Total complication rate (18.2% in group
A vs. 23.1% in group B) did not showed significant differences (P=0.5049).
Conclusions: The two systems used in our study resulted equivalent in terms of US needle visibility,
efficacy, symptom/cosmetic relief, safety. More patients and a longer follow-up are necessary to confirm our
results.
Tipologia CRIS:
14.a.1 Articolo su rivista
Keywords:
Ablation techniques; radiofrequency ablation (RFA); thyroid nodule
Elenco autori:
Francesco, Morelli; Anna Maria Ierardi, ; Giovanni, Pompili; Andrea, Sacrini; Pierpaolo, Biondetti; Salvatore Alessio Angileri, ; Giovanni, Montesano; Mario, Petrillo; Roberta, Giacchero; Gianlorenzo, Dionigi; Gianpaolo, Carrafiello
Link alla scheda completa:
Pubblicato in: